These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 19069157)
1. [Fabry disease in light of recent review]. Uyama E Brain Nerve; 2008 Nov; 60(11):1235-44. PubMed ID: 19069157 [TBL] [Abstract][Full Text] [Related]
2. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene. Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062 [TBL] [Abstract][Full Text] [Related]
3. Genetics and Gene Therapy of Anderson-Fabry Disease. Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309 [TBL] [Abstract][Full Text] [Related]
4. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372 [TBL] [Abstract][Full Text] [Related]
5. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment. Mahmud HM J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811 [TBL] [Abstract][Full Text] [Related]
6. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529 [TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic investigation of a Japanese family with cardiac fabry disease. Identification of a novel α-galactosidase A missense mutation (G195V). Nakagawa N; Maruyama H; Ishihara T; Seino U; Kawabe J; Takahashi F; Kobayashi M; Yamauchi A; Sasaki Y; Sakamoto N; Ota H; Tanabe Y; Takeuchi T; Takenaka T; Kikuchi K; Hasebe N Int Heart J; 2011; 52(5):308-11. PubMed ID: 22008442 [TBL] [Abstract][Full Text] [Related]
15. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C. Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928 [TBL] [Abstract][Full Text] [Related]
16. [Manifestation of Fabry disease in a heterozygous female patient. New perspectives using enzyme replacement therapy]. Jansen T; Brokalaki E; Hillen U; Hentschke M; Grabbe S Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1590-3. PubMed ID: 16823707 [TBL] [Abstract][Full Text] [Related]
18. Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Tanaka M; Ohashi T; Kobayashi M; Eto Y; Miyamura N; Nishida K; Araki E; Itoh K; Matsushita K; Hara M; Kuwahara K; Nakano T; Yasumoto N; Nonoguchi H; Tomita K Clin Nephrol; 2005 Oct; 64(4):281-7. PubMed ID: 16240899 [TBL] [Abstract][Full Text] [Related]
19. [Fabry's disease; towards a treatment]. Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093 [TBL] [Abstract][Full Text] [Related]
20. [Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients]. Cianciaruso B; Pisani A; Andreucci MV; Parente N; Andria G; Federico S; Sabbatini M; Sessa A G Ital Nefrol; 2003; 20(2):113-9. PubMed ID: 12746795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]